BRACE Home / Study team
Meet Professor Nigel Curtis and the BRACE trial team
Almost 400 researchers and staff across five countries are involved in the BRACE BCG vaccine trial study team.
Prof Nigel Curtis, BRACE trial Chief Principal Investigator
Professor Nigel Curtis is a paediatric infectious diseases physician and clinician scientist. He is the leader of the Infectious Diseases Research Group at the Murdoch Children's Research Institute, Professor of Paediatric Infectious Diseases at The University of Melbourne and Head of Infectious Diseases at The Royal Children's Hospital Melbourne.
The BRACE trial is a randomised controlled clinical trial working to determine if BCG vaccination reduces the impact of COVID-19 and other diseases in healthcare workers. Since launching in March 2020, the trial has recruited more than 6800 participants in five countries.
A global effort to study BCG off-target effects
International Principal Investigators from 36 sites
Western AustraliaPeter Richmond
South AustraliaDavid Lynn
New South WalesNicholas Wood
The NetherlandsMarc Bonten
Cristina Prat Aymerich
Jaap ten Oever
SpainJesús Rodríguez Baño
Tomás Perez Porcuna
Maria Carmen Fariñ Álvarez
United KingdomJohn Campbell
The BRACE trial - one year on
Prof Curtis, international Principal Investigators, Ann Ginsberg of the Bill & Melinda Gates Foundation and the global study team celebrate one year since the trial began.
BRACE marks Clinical Trials Day 2021
Hear from Ann Ginsberg, of the Bill & Melinda Gates Foundation, about how the BRACE trial has risen to the challenge of running the largest BCG vaccine study for healthcare workers during the global pandemic.
Brazil joins the BRACE trial
Pulmonologist, Professor Margareth Dalcolmo, coordinator of the BRACE trial Brazil in Rio de Janeiro, called on healthcare professionals to join the study in January 2021.